These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30773367)

  • 1. Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan.
    Xie J; de Souza Alves V; von der Haar T; O'Keefe L; Lenchine RV; Jensen KB; Liu R; Coldwell MJ; Wang X; Proud CG
    Curr Biol; 2019 Mar; 29(5):737-749.e5. PubMed ID: 30773367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
    Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
    Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy.
    Moore CE; Wang X; Xie J; Pickford J; Barron J; Regufe da Mota S; Versele M; Proud CG
    Cell Signal; 2016 Apr; 28(4):284-93. PubMed ID: 26795954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.
    Bianco C; Thompson L; Mohr I
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22583-22590. PubMed ID: 31636182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases.
    Beretta S; Gritti L; Verpelli C; Sala C
    Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.
    Xie J; Shen K; Lenchine RV; Gethings LA; Trim PJ; Snel MF; Zhou Y; Kenney JW; Kamei M; Kochetkova M; Wang X; Proud CG
    Int J Cancer; 2018 May; 142(9):1865-1877. PubMed ID: 29235102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.
    Leprivier G; Remke M; Rotblat B; Dubuc A; Mateo AR; Kool M; Agnihotri S; El-Naggar A; Yu B; Somasekharan SP; Faubert B; Bridon G; Tognon CE; Mathers J; Thomas R; Li A; Barokas A; Kwok B; Bowden M; Smith S; Wu X; Korshunov A; Hielscher T; Northcott PA; Galpin JD; Ahern CA; Wang Y; McCabe MG; Collins VP; Jones RG; Pollak M; Delattre O; Gleave ME; Jan E; Pfister SM; Proud CG; Derry WB; Taylor MD; Sorensen PH
    Cell; 2013 May; 153(5):1064-79. PubMed ID: 23706743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and roles of elongation factor 2 kinase.
    Proud CG
    Biochem Soc Trans; 2015 Jun; 43(3):328-32. PubMed ID: 26009171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling.
    Wang X; Regufe da Mota S; Liu R; Moore CE; Xie J; Lanucara F; Agarwala U; Pyr Dit Ruys S; Vertommen D; Rider MH; Eyers CE; Proud CG
    Mol Cell Biol; 2014 Nov; 34(22):4088-103. PubMed ID: 25182533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicuculline regulated protein synthesis is dependent on Homer1 and promotes its interaction with eEF2K through mTORC1-dependent phosphorylation.
    Gladulich LFH; Xie J; Jensen KB; Kamei M; Paes-de-Carvalho R; Cossenza M; Proud CG
    J Neurochem; 2021 May; 157(4):1086-1101. PubMed ID: 32892352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA.
    Wu Y; Xie J; Jin X; Lenchine RV; Wang X; Fang DM; Nassar ZD; Butler LM; Li J; Proud CG
    Biochem J; 2020 Nov; 477(22):4367-4381. PubMed ID: 33094805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer.
    Fu LL; Xie T; Zhang SY; Liu B
    Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation.
    Lim JKM; Samiei A; Delaidelli A; de Santis JO; Brinkmann V; Carnie CJ; Radiloff D; Hruby L; Kahler A; Cran J; Leprivier G; Sorensen PH
    Cell Death Dis; 2024 Jul; 15(7):501. PubMed ID: 39003251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans.
    Hansen M; Taubert S; Crawford D; Libina N; Lee SJ; Kenyon C
    Aging Cell; 2007 Feb; 6(1):95-110. PubMed ID: 17266679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity.
    Jan A; Jansonius B; Delaidelli A; Bhanshali F; An YA; Ferreira N; Smits LM; Negri GL; Schwamborn JC; Jensen PH; Mackenzie IR; Taubert S; Sorensen PH
    Acta Neuropathol Commun; 2018 Jul; 6(1):54. PubMed ID: 29961428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.
    Kruiswijk F; Yuniati L; Magliozzi R; Low TY; Lim R; Bolder R; Mohammed S; Proud CG; Heck AJ; Pagano M; Guardavaccaro D
    Sci Signal; 2012 Jun; 5(227):ra40. PubMed ID: 22669845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy.
    Vilchinskaya N; Lim WF; Belova S; Roberts TC; Wood MJA; Lomonosova Y
    Am J Pathol; 2023 Jun; 193(6):813-828. PubMed ID: 36871751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elongation factor eEF2 kinase and autophagy jointly promote survival of cancer cells.
    Lenchine RV; Rao SR; Wang X; Fang DM; Proud CG
    Biochem J; 2021 Apr; 478(8):1547-1569. PubMed ID: 33779695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress.
    Xie J; Van Damme P; Fang D; Proud CG
    J Biol Chem; 2019 May; 294(18):7169-7176. PubMed ID: 30890561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine growth restriction inhibits expression of eukaryotic elongation factor 2 kinase, a regulator of protein translation.
    McKnight RA; Yost CC; Zinkhan EK; Fu Q; Callaway CW; Fung CM
    Physiol Genomics; 2016 Aug; 48(8):616-25. PubMed ID: 27317589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.